EyePoint Pharmaceuticals Inc.

Stock Earnings

EyePoint Pharmaceuticals Inc’s filing revealed that its Director Zaderej Karen L. acquired Company’s shares for reported $27350.0 on May 15

Analysts Viewpoint

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

EyePoint Pharmaceuticals Inc’s recent filing unveils that its Director ANTHONY P. ADAMIS acquired Company’s shares for reported $0.67 million on

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Tag: EyePoint Pharmaceuticals Inc.